Sign Up

Get the InvestingChannel
Free e-Letter Today

Learn More

Independent market opinion, analysis and ideas - delivered every business day

Premium market opinions, analysis, and ideas - delivered every business day

The Channel

  1. “THE GROWING RISK OF A 2020 RECESSION...

    32 minutes ago
    Silver Doctors
  2. Talked Out of a Gold Rally While...

    about 1 hour ago
    Silver Doctors
  3. BMO upgrades Bank of America to...

    about 2 hours ago
    The Fly
  4. “Beyond Ridiculous” – Trader Warns The...

    about 2 hours ago
    Silver Doctors
  5. Fly Intel: Wall Street's top stories...

    about 2 hours ago
    The Fly
  6. Positive Finish for TSX

    about 2 hours ago
    Baystreet.ca
  7. Stocks Gain in Lead-up to Fed Meeting

    about 2 hours ago
    Baystreet.ca
  8. Will A False-Flag Iran War Cause A...

    about 2 hours ago
    Silver Doctors

Trade Idea of the Day Presented by: Baystreet.ca

Tesla Makes Last Hard Push To Break Record Sales This Quarter

Tesla is well on its way to having a record sales quarter, and is currently delivering a thousand cars per day on average this month, Electrek reported on Friday, despite many missed deadlines and sales figures for previous quarters. The push comes US incentives for buying electric vehicles are set to drop again at... Read More

Stocks Progress in Lead-up to Fed Meeting

Stocks rose slightly on Monday as investors looked ahead to a crucial Federal Reserve meeting this week. The Dow Jones Industrial Average retained 57.9 to pause for lunch at 26,147.51. The S&P 500 eked ahead 4.64 points at 2,891.58 The NASDAQ Composite 48.24 points to 7,844.90, as tech shares gained. Facebook acquired 2.6%, and Netflix climbed 3.1%, while Amazon advanced 1%. Alphabet and Apple both traded nearly 1% higher. Disney shares slipped 0.6% after an analyst at Imperial Capital downgraded the stock to in-line from outperform, citing a “record ” valuation. Shares of auction house Sotheby’s shot up nearly 60% on news it will be bought for $3.7 billion by BidFair USA. Array BioPharma shares also surged nearly 60% after the company was acquired by Pfizer for $10.6 billion. Equities posted slight gains...

Pfizer to Buy Array for $10.6B

Pfizer (NYSE: PFE) said on Monday it would acquire Array Biopharma (NASDAQ: ARRY) for $10.64 billion in cash, giving it access to the target’s approved drugs for skin cancer and the targeted cancer medicines in its pipeline. The offer of $48 per Array share represents a premium of about 62% to the stock’s close on Friday. Array’s shares hiked $17.01, 57.5%, to $46.60 in early Monday trade. Array's portfolio includes the approved combined use of BRAFTOVI® (encorafenib) and MEKTOVI® (binimetinib) for the treatment of BRAFV600E or BRAFV600K mutant unresectable or metastatic melanoma. The combination therapy has significant potential for long-term growth via expansion into additional areas of unmet need and is currently being investigated in over 30 clinical trials across several solid...

Apollo Wins FDA Nod

Apollo Endosurgery Inc (NASDAQ:APEN) disclosed that it has received FDA approval for its labeling updates for the ORBERA Intragastric Balloon System. The Austin, Texas-based Apollo, which boasts a status as a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced the nod Thursday. The goal of the labeling updates is to improve patient safety and these will take effect immediately. The labeling updates improve patient safety by providing further definition and guidance on the appropriate use of the ORBERA® Intragastric Balloon System and patient selection. The most notable safety labeling updates included: Clarification to contraindications. These changes clarified that the previous "hepatic insufficiency or cirrhosis" contraindication related to patients with acute...

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Transocean (RIG) downgraded to Neutral from Buy at Citi with analyst Scott Gruber saying his organic cash burn analysis implies the drillers will burn cash until "at least" 2021. 2. CommScope (COMM) downgraded to Outperform from Strong Buy at Raymond James with analyst Simon Leopold saying he is concerned that performance of the acquired ARRIS business will be worse than expected. 3. Spirit AeroSystems (SPR), Astronics (ATRO), and Barnes Group (B) were downgraded to Sell from Hold at SunTrust while Woodward (WWD) and Ducommun (DCO) were downgraded to Hold from Buy. 4. Melinta Therapeutics (MLNT) downgraded to Underweight from Neutral at JPMorgan with...

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Cooper-Standard (CPS) downgraded to Sell from Neutral at Goldman Sachs with analyst David Tamberrino saying the company's production-levered content is "not differentiated enough to fight the cycle" and its exposure to manufacturers, particularly to Ford (F), is unfavorable. 2. Marathon Oil (MRO) downgraded to Neutral from Overweight at Atlantic Equities with analyst Barry Maccarthy citing crude oil price concerns for the downgrade. 3. CyrusOne (CONE) downgraded to Neutral from Buy at UBS with analyst John Hodulik saying he expects the company to benefit from long-term secular trends in the data center industry but has growing concerns that near-term hyperscale demand will remain "subdued" longer than expected.Union Pacific (UNP) downgraded...

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Delphi Technologies (DLPH) upgraded to Buy from Neutral at Goldman Sachs with analyst David Tamberrino saying new CEO Rick Dauch's more operationally focused initiatives should drive "idiosyncratic" margin and free cash flow expansion into 2020. 2. Williams-Sonoma (WSM) upgraded to Accumulate from Hold at Gordon Haskett with analyst Chuck Grom saying following the meetings, and based on more upbeat than expected results from peer RH (RH), he has a higher degree of confidence about both the company's near-term results and its long-term options. 3. Concert Pharmaceuticals (CNCE) upgraded to Buy from Neutral at Janney Montgomery Scott with analyst Esther Hong saying CTP-692...

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Cisco (CSCO) downgraded to Market Perform from Outperform at William Blair with analyst Jason Ader saying he sees "signs of tightening demand" across IT infrastructure, which he believes could pressure growth in Cisco's fiscal 2020, "especially when compared against unusually strong demand in fiscal 2019." 2. Manpower (MAN) downgraded to Neutral from Outperform at Credit Suisse. 3. Dave & Buster's (PLAY) downgraded to Hold from Buy at Gordon Haskett and SunTrust, as well as to Market Perform from Outperform at Wells Fargo. 4. Amcor (AMCR) reinstated with a Sell from Neutral at Goldman Sachs with analyst Brian Maguire saying Bemis's earnings growth "has not proven to be as resilient in recent years." 5. Beyond Meat (BYND)...

Stocks Fall for Second Straight Day as Rally Pauses

Stocks fell for a second day on Wednesday as Wall Street took a pause following a strong rally to kick off June. The Dow Jones Industrial Average dwindled 6.02 points to 26,042.59. The S&P 500 was unchanged at 2,885.59. The NASDAQ Composite slid 13.78 points to 7,808.78. Chipmakers contributed to the decline. Lam Research lost 3.9%. Applied Materials, KLA-Tencor and Teradyne also fell. Semiconductor stocks were pressured after an Evercore ISI analyst said a recovery in the space will likely be pushed back to the second half of 2020. Bank shares fell along with Treasury yields. Citigroup dropped 1% while J.P. Morgan Chase gave back 0.5%, and Bank of America slid 0.8%. Still, the major indexes were all up nearly 5% for the month...

Recent Tweets @InvestChannel

Follow Us on Twitter